An assessment of hormone replacement therapy to prevent postmenopausal osteoporosis.
Dören
M
M
Academic Department of Obstetrics and Gynaecology, King's College Hospital, London, UK.
D016022:Case-Control Studies; D015331:Cohort Studies; D004958:Estradiol / Q000008:administration & dosage*; D045166:Estradiol Congeners / Q000008:administration & dosage; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000008:administration & dosage; D004970:Estrone / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008875:Middle Aged; D009652:Norpregnenes / Q000008:administration & dosage; D015663:Osteoporosis, Postmenopausal / Q000517:prevention & control*; D016032:Randomized Controlled Trials as Topic
D045166:Estradiol Congeners; D004966:Estrogens, Conjugated (USP); D009652:Norpregnenes; D004970:Estrone; D004958:Estradiol; C027385:tibolone